drugset / Trial / NCT00003479
Antineoplaston Therapy in Treating Patients With Ependymoma
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Current therapies for patients with ependymoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of patients with ependymoma . PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with ependymoma.
Timeline
- Start
- 1966-07
- Primary completion
- 2000-10
- Completion
- 2000-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Astugenal | Unknown | — | Intravenous |
| Subject | antineoplaston A10 | Small molecule | — | Intravenous |